US BANCORP \DE\ - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 79 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$526
-25.5%
2000.0%0.00%
Q2 2023$706
+14.2%
2000.0%0.00%
Q1 2023$618
-27.0%
2000.0%0.00%
Q4 2022$8462000.0%0.00%
Q3 2022$0
-100.0%
2000.0%0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,0000.0%2000.0%0.00%
Q4 2021$1,0000.0%2000.0%0.00%
Q3 2021$1,000
-80.0%
200
-60.8%
0.00%
Q2 2021$5,0000.0%5100.0%0.00%
Q1 2021$5,0000.0%5100.0%0.00%
Q4 2020$5,0000.0%5100.0%0.00%
Q3 2020$5,0000.0%5100.0%0.00%
Q2 2020$5,000
+150.0%
510
+155.0%
0.00%
Q1 2020$2,0000.0%2000.0%0.00%
Q4 2019$2,0000.0%2000.0%0.00%
Q3 2019$2,000
-33.3%
2000.0%0.00%
Q2 2019$3,000
-62.5%
2000.0%0.00%
Q1 2019$8,000
+300.0%
200
+100.0%
0.00%
Q4 2018$2,000
-60.0%
1000.0%0.00%
Q3 2018$5,000
-28.6%
100
-13.8%
0.00%
Q2 2018$7,000
-61.1%
116
-57.7%
0.00%
Q1 2018$18,000
+80.0%
274
+174.0%
0.00%
Q4 2017$10,000
-77.3%
100
-73.1%
0.00%
Q3 2017$44,000
+2100.0%
372
+431.4%
0.00%
Q4 2016$2,000
-71.4%
70
+22.8%
0.00%
Q2 2015$7,000
-93.8%
57
-88.2%
0.00%
Q1 2015$113,000
+21.5%
482
-1.6%
0.00%
Q4 2014$93,000
+5.7%
490
+32.1%
0.00%
Q3 2014$88,000
+2100.0%
371
+550.9%
0.00%
Q2 2014$4,000
-94.7%
57
-92.2%
0.00%
Q1 2014$76,000
+261.9%
727
+263.5%
0.00%
Q4 2013$21,0002000.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,300,000$12,636,0002.61%
AIGH Capital Management LLC 964,590$9,376,0001.97%
Worth Venture Partners, LLC 226,758$2,204,0001.07%
Camber Capital Management LP 2,555,000$24,835,0000.85%
Palo Alto Investors LP 1,392,997$13,540,0000.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,769,795$36,642,0000.77%
GLOBEFLEX CAPITAL L P 428,680$4,167,0000.76%
Zebra Capital Management LLC 34,243$333,0000.37%
Sofinnova Investments, Inc. 344,917$3,353,0000.20%
RICE HALL JAMES & ASSOCIATES, LLC 605,792$5,888,0000.19%
View complete list of PUMA BIOTECHNOLOGY INC shareholders